Provides an overview of the Government Accountability Office’s (GAO) review of 258 nongovernmental hospitals that participate in the 340B Drug Pricing Program and their contracts with state and local governments. Evaluates the contracts to determine if they meet the eligibility requirement to serve low-income individuals. Outlines weaknesses in the Health Resources and Services Administration’s review of the hospital contracts and offers six recommendations to improve the contract review process.
